Feed SNWGF
Summary
21 / 100 · Bulios Score
Valuation 0Growth -Profitability -Quality 0Debt 69Stability 29
What speaks for it
- It holds more cash than debt: $35.0M against $156.1K.
- The price moves less than the market (beta 0.62).
What to watch
- It passes only 1 of the 9 points of the Piotroski financial health test.
- It missed profit estimates 5 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveIs it growing?
Revenue (CAD)
202120222024202520262027
Diluted EPS (CAD)
202120222024202520262027
- Analyst estimate
There is not enough revenue history yet to say how fast it grows.
Growth in detailDoes it make money?
Over the last 12 months it made a loss of $62.7M.
Profitability in detailIs it financially healthy?
YesCash and short-term investments $85.7M
Debt $156.1K
Free cash flow over 12 months -$68.6M
Over the last 12 months it spent more cash than it brought in. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 2
- Hold 0
- Sell 0
No analyst has published a price target.
100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.